3
Announcements
Trials
Browse
Landscape
Status
Completed
2
Unknown
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Melanoma
8
Carcinoma, Non-Small-Cell Lung
6
Breast Neoplasms
5
Pancreatic Neoplasms
4
Neoplasms
4
Colorectal Neoplasms
4
Stomach Neoplasms
3
Prostatic Neoplasms
3
Head and Neck Neoplasms
3
Esophageal Neoplasms
3
Carcinoma, Basal Cell
3
Barrett Esophagus
3
Squamous Cell Carcinoma of Head and Neck
2
Rectal Neoplasms
2
Ovarian Neoplasms
2
Neuroendocrine Tumors
2
Lung Neoplasms
2
Liver Neoplasms
2
Inflammatory Bowel Diseases
2
Colonic Neoplasms
2
Breast Neoplasms, Male
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Tuberculosis
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Thyroid Diseases
1
Squamous Intraepithelial Lesions
1
Small Cell Lung Carcinoma
1
Interventions
Drug Therapy
4
apatinib
3
Oxaliplatin
3
pemigatinib
2
pembrolizumab
2
cemiplimab
2
avelumab
2
atezolizumab
2
S 1 (combination)
2
Nivolumab
2
Leucovorin
2
Irinotecan
2
Folfox protocol
2
Fluorouracil
2
Everolimus
2
Erlotinib Hydrochloride
2
Endoscopic Mucosal Resection
2
Docetaxel
2
Capecitabine
2
CGX1321
2
vandetanib
1
titanium silicide
1
tepotinib
1
tegafur-gimeracil-oteracil
1
talazoparib
1
sodium thiosulfate
1
selpercatinib
1
rucaparib
1
pralsetinib
1
ponatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Gastrointestinal Neoplasms
×
Biopsy
×
Clear all
NCT03228095
2018-08-21
Volatolome
University of Latvia
Unknown
3,000 enrolled